suPARnostic® Approval in India

Wed Jun 06 2018

suPARnostic® Approval in India

The suPARnostic® product has been approved by the Central Drugs Standard Control Organisation, New Delhi, and given permission to import, for which Form 10 license was issued in May 2017.

Congratulations to our distributor Super Biotech Pvt Ltd, who already has trials of the suPARnostic® product running at several hospitals in India.

Super Biotech Pvt Ltd has added a new phone number +91 11 45073677 specially for suPAR inquiries in India.

Contact information to Super Biotech – please see here

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates